Neurochemical sensitization in the pathophysiology of schizophrenia: Deficits and dysfunction in neuronal regulation and plasticity

Neuropsychopharmacology

Volumn 17, Issue 4, 1997, Pages 205-229

  Lieberman, Jeffrey A ^a   Sheitman, Brian B ^a   Kinon, Bruce J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Behavioural sensitization; Dopamine; Neuroplasticity; Pathophysiology; Schizophrenia

Indexed keywords

CENTRAL STIMULANT AGENT; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; GLUTAMIC ACID; PSYCHEDELIC AGENT;

BRAIN CELL; HUMAN; HYPOTHESIS; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SENSITIZATION; STRESS;

BRAIN CHEMISTRY; HUMANS; NERVOUS SYSTEM; NEURONAL PLASTICITY; SCHIZOPHRENIA;

EID: 0030774502     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(97)00045-6     Document Type: Review

References (262)

1. Akbarian S, Kim JJ, Potkin SG, Hagman JO, Tafazzoli A, Bunney WE Jr, Jones EG (1995): Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry 52(4):258-278
2. Akbarian S, Bunney WE Jr., Potkin SG, Wigal SB, Hagman, JO, Sandman CA, Jones EG (1993a): Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch Gen Psychiatry 50(3):169-177
3. Akbarian S, Vinuela A, Kim JJ, Potkin SG, Bunney WE Jr, Jones EG (1993b): Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development. Arch Gen Psychiatry 50(3):178-187
4. Alberini CM, Ghiradi M, Metz R, Kandel ER (1994): C/EMP is an immediate early gene required for the consolidation of long term facilitation in the aplasia. Cell 76(6): 1099-1114
5. American Psychiatric Association (1994): Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC, American Psychiatric Press
6. Anderson SA, Volk DW, Lewis DA (1995): Increased density of microtubule associated protein 2-immunoreactive neurons in the prefrontal white matter of schizophrenic subjects. Schizophr Res 19:111-119
7. Andreasen NC, Arndt S, Alliger R, Miller D, Flaum M (1995): Symptoms of schizophrenia: methods, meanings and mechanisms. Arch Gen Psychiatry 52(5):341-351
8. Andreasen NC, Carpenter WT Jr (1993): Diagnosis and classification of schizophrenia. Schizophr Bull 19(2):199-214
9. Angrist BM, Gershon S (1970): The phenomenology of experimentally induced amphetamine psychosis-preliminary observation. Biol Psychiatry 2:95-107
10. Angrist BM, Sathananthan G, Wilk S, Gershon S (1974): Amphetamine psychosis: behavioral and biochemical aspects. J Psychiatr Research 11:13-23
11. Angrist B, Rotrosen J, Gershon S (1980): Responses to apomorphine, amphetamine, and neuroleptics in schizophrenic subjects. Psychopharmacology 67:31-88
12. Antelman SM, Eichler AJ, Black CA, Kocan D (1980): Interchangeability of stress and amphetamine in sensitization. Science 207(4428):329-331
13. Antelman SM, Kocan D, Edwards DJ, Knopf S, Perel JM, Stiller R (1986): Behavioral effects of a single neuroleptic treatment grow with the passage of time. Brain Res 385(1):58-67
14. Arnold SE, Franz BR, Gur RC, Gur RE, Shapiro RM, Moberg PJ, Trojanowski JQ (1995): Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions. Am J Psychiatry 152(5):738-748
15. Bailey CH, Chen M (1983): Morphological basis of long term habituation and sensitization in Aplasia. Science 220:91-93
16. Barta PE, Pearlson GD, Powers RE, Richards SS, Tune LE (1990): Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia. Am J Psychiatry 147(11):1457-1462
17. Benes FM (1995a): Is there a neuroanatomic basis for schizophrenia? An old question revisited. The Neuroscientist 1(2):104-115
18. Benes FM (1995b): Development of the glutamate, GABA and dopamine systems in relation to NRH-indiced neurotoxicity. Biol Psychiatry 38(12):783-787
19. Bloom FE (1993): Advancing a neurodevelopmental origin for schizophrenia. Arch Gen Psychiatry 50(3):224-227
20. Bogerts B (1993): Recent advances in the neuropathology of schizophrenia. Schizophr Bull 19(2):431-445
21. Bogerts B, Lieberman JA, Ashtari M, Bilder R, Degreef G, Lerner G, Johns C, Masiar S (1993): Hippocampus-amygdala volumes and psychopathology in chronic schizophrenia. Biol Psychiatry 33:236-246
22. Bogerts B, Ashtari M, Degreef G, Alvir JM, Bilder RM, Lieberman JA (1990): Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia. Psychiatr Res 35(1):1-13
23. Bracha HS, Torrey EF, Bigelow LB, Lohr JB, Linington BB (1991): Subtle signs of prenatal maldevelopment of the hand ectoderm in schizophrenia: A preliminary monozygotic twin study. Biol Psychiatry 30:719-725
24. Braff D, Stone C, Callaway E, Glick I, Bali L (1978): Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 15(4):339-343
25. Breier A, Su TP, Saunders R, Carson RE, Kolachana BA, de Bartolomeis A, Weinberger DR, Weisenfeld N, Malhotra AK, Eckelman WC, Pickar D (1997): Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proceedings of the National Academy of Sciences 94(6):2569-2574
26. Bremner JD, Southwick SM, Johnson DR, Yehuda R, Charney DS (1993): Childhood abuse in combat-related posttraumatic stress disorders. Am J Psychiatry 150(2):235-239
27. Bunney BS, Grace AA (1978): Acute and chronic haloperidol treatment: comparison of effects on nigral dopaminergic cell activity. Life Sci 23:1715-1728
28. Cain DP (1989): Long term potentiation and kindling: how similar are the mechanisms? Trends Neurosci 12(1):6-10
29. Carlsson M, Carlsson A (1990): Interactions between glutamatergic and monoaminergic systems within the basal ganglia - implications for schizophrenia and Parkinson's disease. Trends Neurosci 13(7):272-276
30. Carpenter, WT Jr, Buchanan RV, Kirkpatrick B, Tamminga C, Wood F (1993): Strong inference, theory testing, and the neuroanatomy of schizophrenia. Arch Gen Psychiatry 50:825-831
31. Carpenter WT Jr, Kirkpatrick B (1988): The heterogeneity of the long term course of schizophrenia. Schizophr Bull 14(4):645-652
32. Carpenter WT, Buchanan RW, Breier A, Kirkpatrick B, et al. (1991): Psychopathology and the question of neurodevelopmental or neurodegenerative disorder. Schizophr Res 5(3):192-194
33. Charney DS, Deutch AY, Krystal JH, Southwick SM, Davis M (1993): Psychobiologic mechanisms of posttraumatic stress disorder. Arch Gen Psychiatry 50:294-305
34. Chevalier G, Deniau JM (1990): Disinhibition as a basic process in the expression of striatal functions. Trends Neurosci 13(7):277-280
35. Choi DW, Rothman SM (1990): The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci 13:171-182
36. Choi DW (1988): Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:623-634
37. Coppens HJ, Slooff CJ, Paans AMJ, Wiegman T, Vallburg W, Korf J (1991): High central D2-dopamine receptor occupancy as assessed with positron emission tomography in medicated but therapy-resistant schizophrenic patients. Biol Psychiatry 29(7):629-634
38. Costall B, Naylor RJ (1977): Mesolimbic and extrapyramidal sites for the mediation of stereotyped behavior patterns and hyperactivity by amphetamine and apomorphine in the rate. Advances in Behavior and Biology 21:47-76
39. Cotman CW, Monaghan DT, Ganong AH (1988): Excitatory amino acid neurotransmission: NMDA receptors and Hebb-type synaptic plasticity. Annu Rev Neurosci 11: 61-80
40. Coyle JT (1995): Glutamate, oxidative stress and schizophrenia. 5th International Congress on Schizophrenia Research. Hot Springs, Virginia
41. Coyle JT, Puttfarcken P (1993): Oxidative stress, glutamate, and neurodegenerative disorders. Science 262(5134): 689-695
42. Creese I, Burt DR, Snyder SH (1976): Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192:480-483
43. Crow TJ (1990a): Temporal lobe asymmetries as the key to the etiology of schizophrenia. Schizophr Bull 16(3):433-443
44. Crow TJ (1990b): The continuum of psychosis and its genetic origins. Br J Psychiatry 156:788-797
45. Crow TJ, MacMillan JF, Johnson AL, Johnstone EC (1986): A randomised controlled trial of prophylactic neuroleptic treatment. Br J Psychiatry 148:120-127
46. Crow TJ (1985): The two-syndrome concept:origins and current status. Schizophr Bull 11(3):471-486
47. Crow TJ (1980): Molecular pathology of schizophrenia: more than one dimension of pathology? BMJ 280:66-68
48. Csernansky JG, Bellows EP, Barnes DE, Lombrozo L (1990): Sensitization versus tolerance to the dopamine turnover elevating effects of haloperidol: the effect of regular/ intermittent dosing. Psychopharmacology(Berl) 101(4): 519-524
49. Csernansky JG, Mellentin J, Beauclair L, Lombrozo L (1988): Mesolimbic dopaminergic supersensitivity following electrical kindling of the amygdala. Biol Psychiatry 23: 285-294
50. Davis KL, Kahn RS, Ko G, Davidson M (1991): Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 148(11):1474-1486
51. Daviss SR, Lewis DA (1995): Local circuit neurons of the prefrontal cortex in schizophrenia: selective increase in the density of calbindin-immunoreactive neurons. Psychiat Res 59:81-96
52. Deutch AY (1992): The regulation of subcortical dopamine systems by the prefrontal cortex: interactions of central dopamine systems and the pathogenesis of schizophrenia. J Neural Transm Suppl 36:61-89
53. Done DJ, Crow TJ, Johnstone EC, Sacker A (1994): Childhood antecedents of schizophrenia and affective illness: social adjustment at ages 7 and 11. BMJ 309:699-703
54. Dragunow M, Robertson GS, Faull RL, Robertson HA, Jansen K (1990): D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons. Neuroscience 37(2):287-294
55. Dragunow M, Currie RW, Faull LM, Robertson HA, Jansen K (1989): Immediate-early genes, kindling and long term potentiation. Neurosci Biobehav Rev 13:301-313
56. Ellinwood EH Jr (1971): "Accidental conditioning" with chronic methamphetamine intoxication: implications for a theory of drug habituation. Psychopharmacologia(Berl) 21(2):131-138
57. Erlenmeyer-Kimling L, Cornblatt B (1987): High-risk research in schizophrenia: A summary of what has been learned. J Psychiatr Res 21(4):401-411
58. Fabre M, Rolls ET, Ashton JP, Williams G (1983): Activity of neurons in the ventral tegmental area of the behaving monkey. Behavior and Brain Research 9:213-235
59. Farde L, Wiesel FA, Stone-Elander S, Halldin C, Nordstrom AL, Hall H, Sedvall G (1990): D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C] raclopride. Arch Gen Psychiatry 47(3): 213-219
60. Farde L, Ginovart N, Halldin C. PET-study on D2-receptors in reserpine depleted primates. Presented at the 35th Annual Meeting American College of Neuropsychopharmacology, San Juan, Puerto Rico, December 9-13, 1996, p. 25
61. Feinberg I (1982): Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res 17:319-334
62. Fish B (1977): Neurobiologic antecedents of schizophrenia in children: Evidence for an inherited, congenital neurointegrative defect. Arch Gen Psychiatry 34:1297-1313
63. Friedman MJ (1944): Neurobiological sensitization models of post-traumatic stress disorders: their possible relevance to multiple chemical sensitivity syndrome. Toxicol Ind Health 10 (4-5):449-462
64. Fujiwara Y, Kazahya Y, Nakashima M, Sato M, Otsuki S (1987): Behavioral sensitization to methamphetamine in the rat: an ontogenic study. Psychopharmacology 91: 316-319
65. Gersons BR, Carlier IV (1992): Post-traumatic stress disorder: The history of a recent concept. Br J Psychiatry 161:742-748
66. Giros B, Jaber M, Wightman RM, Caron M (1996): Hyperlocomotion and indifference to cocaine and amphetamines in mice lacking the dopamine transporter. Nature (379): 606-612
67. Glenthoj B, Hemmingsen R, Allerup P, Bowlig TG (1990): Intermittent versus continuous neuroleptic treatment in a rat model. Eur J Pharmacol 190(3):275-286
68. Glenthoj B, Hemmingsen R, Barry DI, Allerup P, Bruhn T, Bolwig TG (1993a): Electrical kindling of rats treated discontinuously or continuously with haloperidol. Eur J Pharmacol 236(3):401-409
69. Glenthoj B, Mogensen B, Laursen H, Holm S, Hemmingsen R (1993b): Electrical sensitization of the meso-limbic dopaminergic system in rats: a pathogenetic model for schizophrenia. Brain Res 619:39-54
70. Goddard GV (1967): Development of epileptic seizures through brain stimulation at low intensity. Nature 214:1020-1021
71. Goddard GV, McIntyre DC, Leech DK (1969): A permanent change in brain function resulting from daily electrical stimulation. Experimental Neurology 25(3):295-330
72. Goelet P, Castellucci VF, Schacher S, Kandel ER (1986): The long and the short of long-term memory - a molecular framework. Nature 322(32):419-422
73. Grace AA (1995): The tonic/phasic model of dopamine system regulation: Its relevance for understanding how stimulant abuse can alter basal ganglia function. Drug Alcohol Depend 37:111-129
74. Grace AA (1993): Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia. J Neural Transm 91:111-134
75. Grace AA (1991): Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41(1):1-24
76. Grace AA, Bunney BS (1984): The control of firing pattern in nigral dopamine neurons: burst firing. J Neurosci 4(11):2877-2890
77. Greden JF, Tandon R (1995): Long-term treatment for lifetime disorders? Arch Gen Psychiatry 52(3):197-200
78. Green MF, Bracha HS, Satz P, Christenson CD (1994): Preliminary evidence for an association between minor physical anomalies and second trimester neurodevelopment in schizophrenia. Psychiatry Res 53(2):119-127
79. Greenberg SM, Castellucci VF, Bayley H, Schwartz JH (1987): A molecular mechanism for long term sensitization in Aplasia. Nature 329:62-65.
80. Griffith JD, Cavanaugh J, Oates J (1968). Paranoid episodes induced by drug. JAMA 205(11):39
81. Gur RE, Mozky D, Resnick S, Mosley L, Shastel D, Gallacher F, Arnold S, Karp J, Alari A, Revich M, Gur RC (1995): Resting cerebral glucose metabolism in first-episode and treated patients with schizophrenia. Arch Gen Psychiatry 52:657-667
82. Hafner H, Maurer K, Loffler W, Riecher-Rossler A (1993): The influence of age and sex on the early course of schizophrenia. Br J Psychiatry 162:80-86
83. Hamamura T, Fibiger HC (1993): Enhanced stress induced dopamine release in the prefrontal cortex of amphetamine sensitized rats. Eur J Pharmacol 237(1):65-71
84. Hasselmo ME (1995): Neuromodulation and cortical function: Modeling the physiological basis of behavior. Behav Brain Res 67:1-27
85. Hebb DO (1949): The Organization of Behavior: A Neurophysiological Theory. New York, Wiley
86. Hedner TH, Lundborg P (1985): Development of dopamine autoreceptors in the postnatal rat brain. J Neural Transm 62:53-63
87. Hierholzer R, Munson J. Peabody C, Rosenberg J (1992): Clinical presentation of PTDS in World War II combat veterans. Hosp Community Psychiatry 43(8):816-820
88. Hommer DW, Pert A (1983): The action of opiates in the rat substantia nigra: an electrophysiological analysis. Peptides 4:603-608
89. Hooks MS, Jones GH, Liem BJ, Justice JB Jr (1992): Sensitization and individual differences to IP amphetamine, cocaine, or caffeine following repeated intracranial amphetamine infusions. Pharmacol Biochem Behav 43(3):815-823
90. Huber G, Gross G, Schuttler R, Linz M (1980): Longitudinal studies of schizophrenic patients. Schizophr Bull 6(4):592-605
91. Hurd YL, Weiss F, Koob GF, Ungerststedt NEU (1989): Cocaine reinforcement and extracellular dopamine overflow in rat nucleus accumbens: an in vivo microdialysis study. Brain Res 498:199-203
92. Huttenlocher PR (1979): Synaptic density in the human frontal cortex-developmental changes and the effects of aging. Brain Res 163:195-205
93. Illowsky BP, Juliano DM, Migelow LB, Weinberger DR (1988): Stability of CT scan findings in schizophrenia: results of an 8 year follow-up study. J Neurol Neurosurg Psychiatry 51(2):209-213
94. Innis RB, Malison RT, al-Tikriti M, Hoffer PB, Sybirska EH, Seibyl JP, Zoghbi SS, Baldwin RM, Laruelle M, Smith EO (1992): Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates. Synapse 10(3):177-184
95. Iwanami A, Sugiyama A, Kuroki N, Toda S, Kato N, Nakatani Y, Horita N, Kaneko T (1994): Patients with methamphetamine psychosis admitted to a psychiatric hospital in Japan. A preliminary report. Acta Psychiatrica Scandinavica 89(6):428-432
96. Jackson JH (1931): Selected Writings of John Hughlings Jackson. Vol 1. Taylor J (ed). London, Hodder and Stoughton
97. Jakob H, Beckmann H (1986): Prenatal developmental disturbances in the limbic allocortex in schizophrenics. J Neural Transm 65(3-4):303-326
98. Janowsky DS, el-Yousel MK, Davis JM, Sekerke HJ (1973): Provocation of schizophrenic symptoms by intravenous administration of methylphenidate. Archives of General Psychiatry 28(2):185-191
99. Janowsky DS, Davis JM (1976): Methylphenidate, dextroamphetamine, and levamphetamine. Effects on schizophrenia symptoms. Arch Gen Psychiatry 33:304-308
100. Jaskiw GE, Karoum F, Weinberger DR (1990): Persistent elevations in dopamine and its metabolites in the nucleus accumbens after mild subchronic stress in rats with ibotenic acid lesions of the medial prefrontal cortex. Brain Res 534:321-323
101. Javitt DC, Zukin SR (1991): Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148(10): 1301-1308
102. Javitt DC, Steinschneider M, Schroeder CE, Vaughan HG, Arezzo JC (1994): Detection of stimulus deviance within primate primary auditory cortex: intracortical mechanisms of mismatch negativity generation. Brain Res 667(2):192-200
103. Jeziorski M, White FJ, Wolf ME (1994): MK-801 prevents the development of behavioral sensitization during repeated morphine administration. Synapse 16:137-147
104. Johns JM, Noonan LR (1995): Prenatal cocaine exposure affects social behavior in Sprague-Dawley rats. Neurotoxicology and Teratology 17(5):569-576
105. Kalivas PW, Stewart J (1991): Dopamine transmission in the initiation and expression of drug and stress induced sensitization of motor activity. Brain Res Rev 16:223-244
106. Kalivas PW (1993a): Time course of extracellular dopamine and behavioral sensitization. II. Dopamine perikarya. J Neurose 13(1):276-284
107. Kalivas PW (1993b): Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine. J Pharmacol Exp Ther 267(1):486-495
108. Kalivas PW (1993c): Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res Rev 18(1):75-113
109. Kalivas PW (1993d): Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J Neurosci 13(1):266-275
110. Kalivas PW, Churchill L, Klitenick MA (1993): The circuitry mediating the translation of motivational stimuli into adaptive motor response. In Kalivas PW, Barnes CD (eds), Limbic Motor Circuits and Neuropsychiatry. Boca Raton, CRC Press, pp 237-287
111. Kandel ER (1991): Cellular mechanisms of learning and the biological basis of individuality. In Kandel ER, Schwartz JH, Jessell TM (eds), Principles of Neural Science, 3rd ed. New York, Elsevier
112. Kandel ER, Schwartz JH (1982): Molecular biology of learning: Modulation of transmitter release. Science 218:433-443
113. Kane JM, Lieberman JA (1987): Maintenance pharmacotherapy in schizophrenia. In Meltzer HY (ed), Psychopharmacology: the 3rd Generation of Progress. New York, Raven Press, pp 1103-1109
114. Karler R, Calder LD, Turkanis SA (1991): DNQX blockade of amphetamine behavioral sensitization. Brain Res 552: 295-300
115. Kendler KS, Diehl SR (1993): The genetics of schizophrenia: a current, genetic-epidemiologic perspective. Schizophr Bull 19(2):261-285
116. Kerwin RW (1994): The new atypical antipsychotics. A lack of extrapyramidal side-effects and new routes in schizophrenia research. Br J Psychiatry 164:141-148
117. King GR, Joyner C, Lee T, Kuhn C, Elinwood EH Jr. (1992): Intermittent and continuous cocaine administration: Residual behavioral states during withdrawal. Pharmacol Biochem Behavior 43:342-348
118. Kinzie JD (1993): Posttraumatic effects and their treatment among southeast Asian refugees. In Wilson JP, Raphael B (eds), International Handbook of Traumatic Stress Syndromes. New York, Plenum Press, pp 311-319
119. Kirkby RD, Kokkinidis L (1987): Evidence for a relationship between amphetamine sensitization and electrical kindling of the amygdala. Exp Neurol 97(2):270-279
120. Kirch DG (1993): Infection and autoimmunity as etiologic factors in schizophrenia: A review and reappraisal Schizophr Bull 19(2):355-370
121. Kolta MG, Scalzo FM, Ali SF, Holson RR (1990): Ontogeny of the enhanced behavioral response to amphetamine in amphetamine-pretreated rats. Psychopharmacol 100: 377-382
122. Koob GF (1992): Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13:177-184
123. Kovelman JA, Scheibel AB (1984): A neurohistological correlate of schizophrenia. Biol Psychiatry 19(12):1601-1621
124. Kraepelin E (1919): Dementia Praecox and Paraphrenia. Barkley RM, Robertson GM (eds). Edinburgh, Scotland, E. and S. Livingstone. 1971
125. Lacey MG, Mercuri NB, North RA (1989): Two cell types in rat substantia nigra zona compacta distinguished by membrane properties and the actives of dopamine and opoids. J Neurosci 9:1233-1241
126. Laruelle M, Abi-Dargham A, van Dyck CH, Gil R, D'Souza CD, Erdos J, McCance E, Rosenblatt W, Fingado C, Zoghbi SS, Baldwin RM, Seibyl JP, Krystal JH, Charney DS, Innis RB (1996): Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proceedings of the National Academy of Sciences 93(17):9235-9240
127. Levy AD, Kim JJ, Ellison GD (1988): Chronic amphetamine alters D2 but not D1 agonist induced behavioral responses in rats. Life Sci 43:1207-1213
128. Lewis DA, Anderson SA (1995): The functional architecture of the prefrontal cortex and schizophrenia [editorial] Psychol Med 25:887-894
129. Lewis SW, Murray RM (1987): Obstetrical complications, neurodevelopmental deviance, and risk of schizophrenia. J Psychiatr Res 21:413-421
130. Lieberman JA, Alvir J, Geisler S, Ramos-Lorenzi J, Woerner M, Novacenko H, Cooper T, Kane JM (1994a): Methylphenidate response, psychopathology and tardive dyskinesia as predictors of relapse in schizophrenia. Neuropsychopharmacology 11(2):107-118
131. Lieberman JA, Bogerts B, Degreef G, Ashtari M, Alvir J (1992): Qualitative assessment of brain morphology in acute and chronic schizophrenia. Am J Psychiatry 149(6):784-794
132. Lieberman JA, Kinon BJ, Loebel AD (1990): Dopaminergic mechanisms in idiopathic and drug-induced psychoses. Schizophr Bull 16(1):97-109
133. Lieberman JA, Jody D, Alvir J, Ashtari M, Levy D, Bogerts B, Degreef G, Mayerhoff D, Cooper T (1993a): Brain morphology, dopamine, and eye-tracking abnormalities in first-episode schizophrenia. Arch Gen Psychiatry 50: 357-368
134. Lieberman JA, Jody D, Geisler S, Alvir J, Loebel A, Szymanski S, Woerner M, Borenstein M (1993b): Time course and biological correlates of treatment response in first-episode schizophrenia. Arch Gen Psychiatry 50:369-376
135. Lieberman JA, Kane JM, Alvir JAJ (1987): Provocative tests with psychostimulant drugs in schizophrenia. Psychopharmacology 91:415-433
136. Lieberman JA, Koreen AR (1993): Neurochemistry and neuroendocrinology of schizophrenia: a selective review. Schizophr Bull 19(2):371-429
137. Lieberman J, Koreen A, Loebel A, Geisler S, Alvir J, Volkow N (1994b): Evidence for sensitization in the early stage of schizophrenia. Presented at the XIXth Collegium Internationale Neuro-Psychopharmacologicum Congress, Washington, DC, June 27-July 1
138. Lieberman J, Alvir JM, Koreen A, Geisler S, Chakos M, Sheitman B, Woerner M (1996): Psychobiologic correlates of treatment response in schizophrenia. Neuropsychopharmacology 14(3S):13S-21S
139. Lipska BK, Jaskiw GE, Braun AR, Weinberger DR (1995): Prefontal cortical and hippocampal modulation of haloperidol-induced catalepsy and apomorphine-induced stereotypic behaviors in the rat. Biolog Psychiatry 38(4): 255-262
140. Lipska BK, Jaskiw GE, Chrapusta S, Karoum F, Weinberger DR (1992): Ibotenic acid lesion of the ventral hippocampus differentially affects dopamine and its metabolites in the nucleus accumbens and prefrontal cortex in the rat. Brain Res 585:1-6
141. Lipska BK, Weinberger DR (1993a): Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: A potential animal model of schizophrenia: Neuropsychopharmacology 9(1):67-75
142. Lipska BK, Weinberger DR (1993b): Cortical regulation of the mesolimbic dopamine system: implications for schizophrenia. In Kalivas PW, Barnes CD (eds), Limbic Motor Circuits and Neuropsychiatry. Boca Raton, CRC Press, pp 329-349
143. Loebel AD, Lieberman JA, Alvir JMJ, Mayerhoff DI, Geisler SH, Szymanski SR (1992): Duration of psychosis and outcome in first-episode schizophrenia. Am J Psychiatry 149(9):1183-1188
144. Loebel AD, Lieberman JA, Alvir J, Geisler S, Koreen A, Chakos M (1995): Time to treatment response in successive episodes of early onset schizophrenia. Presented at the International Congress on Schizophrenia Research in Hot Springs, Virginia, April 8-12, 1995
145. Logan J, Dewey SL, Wolf AP, Fowler JS, Brodie JD, Angrist B, Volkow ND, Gatley SJ (1991): Effects of endogenous dopamine on measures of [18F]N-methylspiroperidol binding in the basal ganglia: comparison of simulations and experimental results from PET studies in baboons. Synapse 9(3):195-207
146. Mari JJ, Steiner DL (1994): An overview of family interventions and relapse on schizophrenia: meta-analysis of research findings. Psychol Med 34(3):565-578
147. Marshall BE, Longnecker DE (1990): General anesthetics. In Gilman AG, Rail TW, Nies AS, Tayler P (eds), Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed. New York, Pergamon Press, pp 285-309
148. Martin-Iverson MT, Reimer AR (1994): Effects of nimodopine and/or haloperidol on the expression of conditioned locomotion and sensitization to cocaine in rats. Psychopharmacology 114(2):315-320
149. May PR, Tuma AH, Dixon WJ (1981): Schizophrenia: a followup study of the results of five forms of treatment. Arch Gen Psychiatry 38:776-784
150. McCarley RW, Faux SF, Shenton ME, Nestor PG, Adams J (1991): Event-related potentials in schizophrenia: their biological and clinical correlates and a new model of schizophrenic pathophysiology [Review] [110 refs]. Schizophr Res 4(2):209-231
151. McCarley RW, Shenton ME, O'Donnell BF, Faux SF, Kikinis R, Nestor PG, Jolesz FA (1993): Auditory P300 abnormalities and left posterior superior temporal gyrus volume reduction in schizophrenia. Arch Gen Psychiatry 50(3):190-197
152. McCreadie RG, Williamson DJ, Athawes RW, Connolly MA, Tilak-Singh D (1993): The Nithsdale schizophrenia surveys. XIII. Parental rearing patterns, current symptomatology and relatives expressed emotion. Br J Psychiatry 165(3):347-352
153. McDougle CJ, Black JE, Malison RT, Zimmermann RC, Kosten TR, Heninger GR, Price LH (1994): Noradrenergic dysregulation during discontinuation of cocaine use in addicts. Arch Gen Psychiatry 51(9):713-719
154. McGlashan TH, Fenton WS (1993): Subtype progression and pathophysiologic deterioration in early schizophrenia. Schizophr Bull 19(1):71-84
155. McNamara JO, Yeh G, Bonhaus DW, Okazaki M, Nadler JV (1990): NMDA receptor plasticity in the kindling model. In Ben-Ari Y (ed), Excitatory Amino Acids and Neuronal Plasticity. New York, Plenum Press
156. Mednick SA, Hollister JM (1995): Neural Development in Schizophrenia: Theory and Research. New York, Plenum Press
157. Meltzer HY, Stahl SM (1976): The dopamine hypothesis of schizophrenia: A review. Schizophr Bull 2:19-76
158. Mody I (1993): The molecular basis of kindling. Brain Pathology 3:395-403
159. Morgenson GJ, Brudzynski SM, Wu M, Yang CR, Yim CCY (1993): From motivation to action: a review of dopaminergic regulation of limbic, nucleus accumbens, ventral pallidum, pedunculopontine nucleus circuities involved in limbic-motor integration. In Kalivas PW, Barnes D (eds), Limbic Motor Circuits and Neuropsychiatry. Boca Raton, CRC Press, pp 193-236
160. Murray AM, Hyde TM, Knable MB, Herman MM, Bigelow LB, Carter JM, Weinberger DR, Kleinman JE (1995): Distribution of putative D4 dopamine receptors in postmortem striatum from patients with schizophrenia. J Neurosci 15(3):2186-2191
161. Murray RM, Reveley AM, McGuffin P (1986): Genetic vulnerability to schizophrenia. Psychiatr Clin North Am 9(1):3-16
162. Murray RM, O'Callaghan E, Castle DJ, Lewis SW (1992): A neurodevelopmental approach to the classification of schizophrenia. Schizophr Bull 18(2):319-332
163. Murray RM (1994): Neurodevelopmental schizophrenia: The rediscovery of dementia praecox. Br J Psychiatry (Suppl)25:6-12
164. Neppe VM (1985): Epilepsy and psychiatry: essential links. Psychiatric Insights 2(2):18-22.
165. Nestler EJ, Hope BT, Widnell KL (1993): Drug addiction: A model for the molecular basis of neural plasticity. Neuron 11:995-1006
166. Normon AB, Lu SY, Klug JM, Norgren RB (1993): Sensitization of cFOS expression in rat striatum following multiple challenges with D-amphetamine. Brain Res 603(1): 125-128
167. Norman RM, Malla AK (1993): Stressful life events and schizophrenia. I: A review of the research. Br J Psychiatry 162:161-166
168. O'Donnell P, Grace AA (1995): Synaptic interactions among excitatory afferents to nucleus accumbens neurons: Hippocampal gating of prefrontal cortical input. J Neurosci 15(5 pt 1):3622-3639
169. Olney JW (1989): Excitatory amino acids and neuropsychiatric disorders. Biolog Psychiatry 26:505-525
170. Olney JW, Farber NB (1995): Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52:998-1007
171. Olney JW, Zorunski CF, Stewart GR, Price MT, Want GJ, Labruyere J (1990): Excitotoxicity of L-dopa and 6-OH-dopa: Implications for Parkinson's and Huntington's diseases. Experimental Neurol 108(3):269-272
172. Orner RJ (1992): Post-traumatic stress disorders in European war veterans. Br J Clin Psychol 31:387-403
173. Orr SP (1990): Psychophysiologic studies of post-traumatic stress disorders. In Giller EL (ed), Biological Assessment and Treatment of Post Traumatic Stress Disorder. Washington, DC, American Psychiatric Press
174. Pearce RK, Seeman P, Jellinger K, Tourtellotte WW (1990): Dopamine uptake sites and dopamine receptors in Parkinson's disease and schizophrenia. European J Neurol 30(Suppl 1):9-14
175. Pert A, Post R, Weiss SRB (1992): Conditioning as a critical determinant of sensitization induced by psychomotor stimulants. In Erinoff L (ed), Neurobiology of Drug Abuse: Learning and Memory. Washington, DC, NIDA, p 208
176. Pilowsky LS, Costa DC, Ell PJ, Murray RM, Verhoeff NP, Kerwin RW (1993): Antipsychotic medication, D2 dopamine receptor blockade and clinical response: a 123I IBZM SPET (single photon emission tomography) study. Psychol Med 23(3):791-797
177. Post RM, Weiss SRB (1992a): Endogenous biochemical abnormalities in affective illness: therapeutic versus pathogenic. Biol Psychiatry 32:469-484
178. Post RM (1992b): Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 149:999-1010
179. Post RM, Rubinow DR, Ballenger JC (1986): Conditioning and sensitization in the longitudinal course of affective illness. Br J Psychiatry 149:191-201
180. Post RM (1980): Intermittent versus continuous stimulation: Effect of time interval on the development of sensitization or tolerance. Life Sciences 26:1275-1282
181. Post RM, Kopanda RT (1976): Cocaine, kindling, and psychosis. Am J Psychiatry 133(6):627-634
182. Post RM, Weiss SR, Pert A (1988): Implication of behavioral sensitization and kindling for stress-induced behavioral change. Adv Exp Med Biol 245:441-463
183. Pycock CJ, Carter CJ, Kerwin RW (1980): Effect of 6-hydroxydopamine lesions of the medial prefrontal cortex on neurotransmitter systems in subcortical sites in the rat. J Neurochemistry 34(1):91-99
184. Rada P, Hernandez L (1990): Opposite changes of dopamine turnover in prefrontal cortex and nucleus accumbens after amygdaloid kindling. Neurosci Lett 117:144-148
185. Randrup A, Munkvad I (1965): Special antagonism of amphetamine-induced abnormal behaviour. Inhibition of stereotyped activity with increase of some normal activities. Psychopharmacologia 7(6):416-422
186. Regier DA, Myers JK, Kramer M, Robins LN, Blazer DG, Hough RL, Eaton WW, Locke BZ (1984): The NIMH Epidemiologic Catchment Area program. Historical context, major objectives, and study population characteristics. Arch Gen Psychiatry 41(10):934-941
187. Reith MEA, Benuch M, Lajtha A (1987): Cocaine disposition in the brain after continuous or intermittent treatment of locomotor stimulation in mice. J Pharmacol Experim Therap 243:281-287
188. Robertson HA (1992): Immediate-early genes, neuronal plasticity, and memory. Biochem Cell Biol 70:729-737
189. Robinson TE, Becker JB, Moore CJ, Castaneda E, Mittleman G (1985): Enduring enhancement in frontal cortex dopamine utilization in an animal model of amphetamine psychosis. Brain Res 343(2):374-377
190. Robinson TE, Becker JB (1986): Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis. Brain Res Rev 11: 157-198
191. Robinson TE, Berridge KC (1993): The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev 18(3):247-291
192. Rosen JB, Davis M (1988): Enhancement of acoustic startle by electrical stimulation of the amygdala. Behav Neurosci 102(2):195-202
193. Roth RH, Tam SY, Ida Y, Yang JX, Deutch AY (1988): Stress and the mesocorticolimbic dopamine system. Ann NY Acad Sci 537:138-147
194. Sato K, Morimoto K, Okamoto M (1988): Anticonvulsant action of a non-competitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy. Brain Res 463:12-20
195. Sato M, Numachi Y, Hamamura T (1992): Relapse of paranoid psychotic state in methamphetamine model of schizophrenia. Schizophr Bull 18:115-122
196. Scalzo FM, Holson RR (1992): The ontogeny of behavioral sensitization to phencyclidine. Neurotoxical Teratol 14(1):7-14
197. Schenk S, Snow S (1994): Sensitization to cocaine's motor activating properties produced by electrical kindling of the medial prefrontal cortex but not of the hippocampus. Brain Res 659(1-2):17-22
198. Schultz W, Romo R (1990): Dopamine neurons of the monkey midbrain: contingencies of responses to stimuli eliciting immediate behavioral reactions. J Neurophysiol 63:607-624
199. Sedvall G (1992): The current status of PET scanning with respect to schizophrenia. Neuropsychopharmacology 8(1):41-54
200. Seeger TF, Thai L, Gardner EL (1982): Behavioral and biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: Studies with chronic clozapine and haloperidol. Psychopharmacology 76:182-187
201. Seeman P, Lee T, Chau-Wong M, Wong K (1976): Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261:717-719
202. Seeman P (1987): Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1(2):133-152
203. Seeman P, Bzowej NH, Guan HC, Bergeron C, Reynolds GP, Bird ED, Riederer P, Jellinger K, Tourtellotte WW (1987): Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases. Neuropsychopharmacology 1(1):5-15
204. Seeman P, Van Tol HHM (1994): Dopamine receptor pharmacology. Trends Pharmacol Sci 15:264-270
205. Seeman P, Sunahara RK, Niznik HB (1994): Receptor-receptor link in membranes revealed by ligand competition: example for dopamine D1 and D2 receptors. Synapse 17:62-64
206. Seeman P, Van Tol HH (1995): Dopamine D4-like receptor elevation in schizophrenia: cloned D2 and D4 receptors cannot be discriminated by raclopride capetition agonist [31-1] nemonapride. J Neurochem 64(3):1413-1415
207. Segal DS, Kuczenski R (1992): In vivo microdialysis reveals a diminished amphetamine-induced DA response corresponding to behavorial sensitization produced by repeated amphetamine pretreatment. Brain Res 571: 330-337
208. Seiden LS, Vosmer G (1984): Formation of 6-hydroxydopamine in caudate nucleus of the rat brain after a single large dose of methylamphetamine. Pharmacol Biochem Behavior 21:29-31
209. Selzer JA, Lieberman JA (1993): Schizophrenia and substance abuse. Psychiatr Clin North Am 16(2):401-412
210. Shaw CA, Lanius RA, van den Doel K (1994): The origin of synaptic neuroplasticity: crucial molecules or a dynamical cascade? Brain Res Rev 19:241-263
211. Shenton ME, Kikinis R, Jolesz FA, Pollak SD, LeMay M, Wible CG, Hokama H, Martin J, Metcalf D, Coleman M et al (1992): Abnormalities of the left temporal lobe and thought disorder in schizophrenia. A quantitative magnetic imaging study. N Engl J Med 327(9):604-612
212. Snyder SH (1987): Psychotogenic drugs as models for schizophrenia. Comments on "the current status of the dopamine hypothesis of schizophrenia". Neuropsychopharmacology 1(3):197-199
213. Snyder SH, Banerjee SP, Yamamura HI, Greenberg D (1974): Drugs, neurotransmitters, and schizophrenia. Science 184:1243-1253
214. Solomon Z (1989): Characteristic psychiatric symptomatology of post-traumatic stress disorder in veterans: a three year follow up. Psychol Med 9:927-936
215. Solomon Z, Mikulincer M, Jakob BR (1987): Exposure to recurrent combat stress: Combat stress reactions among Israeli soldiers in the Lebanon War. Psychol Med 17: 433-440
216. Sorg BA, Kalivas PW (1993): Effects of cocaine and footshock stress on extracellular dopamine levels in the medial prefrontal cortex. Neuroscience 53:695-703
217. Sorg BA, Kalivas PW (1991): Effects of cocaine and footshock stress on extracellular dopamine levels in the ventral striatum. Brain Res 559:29-36
218. Southwick SM, Bremmer D, Crystal JH, Charney DS (1994): Psychobiological research in post-traumatic stress disorder. Psychiatr Clin North Am 17(2):251-264
219. Stevens JR (1988): Psychiatric aspects of epilepsy. J Clin Psychiatry Suppl 49:49-57
220. Stewart J, Vezina P (1989): Microinjections of SCH-23990 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systemic amphetamine. Brain Res 495:401-406
221. Suddath RL, Christison GW, Torrey EF, Casanova MF, Weinberger DR (1990): Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia [published erratum appears in N Engl J Med 1990 May 31;322(22):1616] [see comments]. N Engl J Med 322(12):789-794
222. Susser ES, Lin EP (1992): Schizophrenia after prenatal exposure to the Dutch hunger winter of 1944-1945. Arch Gen Psychiatry 49(12):983-988
223. Sutula TP (1990): Experimental models of temporal lobe epilepsy: New insights from the study of kindling and synaptic reorganization. Epilepsia 31(Suppl 3):S45-S54
224. Sweatt JD, Kandel ER (1989): Persistent and transcriptionally-dependant increase in protein phosphorylation in long term facilitation of Aplasia sensory neurons. Nature 339:52-54
225. Takahashi LK, Turner JG, Kalin NH (1992): Prenatal stress alters brain catecholaminergic activity and potentiates stress-induced behavior in adult rats. Brain Res 574(1-2):131-137
226. Tarazi FI, Florign WJ, Creese I (1994): Regulation of dopamine receptor binding following chronic neuroleptic treatment. Society for Neuroscience Abstracts Nov. 1994, p 1772
227. Teyler TJ, DiScenna P (1987): Long-term potentiation. Ann Rev Neurosci 10:131-161
228. Tomb DA (1994): The phenomenology of post-traumatic stress disorder. Psychiatr Clin North Am 17(2):237-250
229. Torrey EF (1991): A viral-anatomical explanation of schizophrenia. Schizophr Bull 17(1):15-18
230. Tsai G, Passani LA, Slusher BS, Carter R, Baer L, Kleinman JE, Coyle JT (1995): Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch Gen Psychiatry 52(1):829-836
231. Tsuang MT, Lyons MJ, Faraone SV (1990): Heterogeneity of schizophrenia: Conceptual models and analytic strategies. Br J Psychiatry. 156:17-26
232. Tsuang MT, Gilbertson MW, Faroane SV (1991): The genetics of schizophrenia. Current knowledge and future directions. Schizophr Res 4:157-171
233. Tsuchida K, Ujike H, Kanzaki A, Fujiwara Y, Akiyama K (1994): Ontogeny of enhanced striatal dopamine release in rats with methamphetamine-induced behavioral sensitization. Pharmacol Biochem Behav 47:161-169
234. Ujike H, Onoue T, Akiyama K, Hamamura T, Otsuki S (1989): Effects of selective D-1 and D-2 dopamine antagonists on development of methamphetamine-induced behavioral sensitization. Psychopharmacology 98(1):89-92
235. Ujike H, Akiyama K, Otsuki S (1990): D-2 but not D-1 dopamine agonists produce augmented behavioral response in rats after subchronic treatment with methamphetamine or cocaine. Psychopharmacology 102: 459-464
236. Umbricht D, Degreef G, Barr WB, Lieberman JA, Pollack S, Schaul N (1995): Postictal and chronic psychoses in patients with temporal lobe epilepsy. Am J Psychiatry 152(2):224-231
237. Van Kammen DP, Docherty JP, Marder SR, Royner JN, Bunney WE Jr (1982): Long-term pimozide pretreatment diffentially affects behavioral responses to dextroamphetamine in schizophrenia. Further exploration of the dopamine hypothesis of schizophrenia. Arch Gen Psychiatry 39(3):275-281
238. Vezina P, Stewart J (1989): The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine. Brain Res 499:108-120
239. Volkow ND, Fowler JS, Wang GJ, Hitzemann R, Logan J, Schlyer DJ, Dewey SL, Wolf AP (1993): Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 14(2):169-177
240. Volkow ND, Wang GJ, Fowler JS, Logan J, Schlyer D, Hitzemann R, Lieberman J, Angrist B, Pappas N, MacGregor R, Burr G, Cooper T, Wolf AP (1994): Imaging endogenous dopamine competition with [11C]raclopride in the human brain. Synapse 16(4):255-262
241. Volkow ND, Ding YS, Fowler C, Wang G-J, Logan J, Gatley JS, Dewey S, Ashby C, Lieberman J, Hitzemann R, Wolf AP (1995): Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch Gen Psychiatry 52(6):456-463
242. Von Voightlander PF, Moore KE (1971): Involvement of nigrostriatal neurons in the in-vivo release of dopamine by amphetamine, amantadine, and tyramine. J Pharmacol Exp Ther 184:542-552
243. Waddington JL, O'Callaghan EO, Youssef HA, Buckley P, Lane A, Cotter D, Larkin C (In press): Schizophrenia as a 'cascade' process and the evidence for its neurodevelopmental original. In Susser E and Gorman L (eds), Epigenetic Causes of Schizophrenia. Washington, DC, American Psychiatric Press
244. Walker E, Downey G, Caspi A (1991): Twin studies of psychopathology: why do the concordance rates vary? Schizophr Res 5(3):211-221
245. Walker E, Lewine RJ (1990): Prediction of adult-onset schizophrenia from childhood home movies of the patients. Am J Psychiatry 147(8):1052-1056
246. Watt NF (1978): Patterns of childhood social development in adult schizophrenics. Arch Gen Psychiatry 35:160-165
247. Wedzony K, Golembiwska K, Klimek V (1993): MK-801 induced symptoms of sensitization. The lack of correlation with the extracellular concentration of dopamine in the rat prefrontal cortex. Brain Res 625(2):333-336
248. Weinberger DR (1995): Models of schizophrenia. 5th International Congress on Schizophrenia Research. Hot Springs, Virginia, April, 1995
249. Weinberger DR, Berman KF, Illowsky BP (1988): Physiologic dysfunction of the prefrontal cortex in schizophrenia: III. A new cohort and evidence of a monoaminergic mechanism. Arch Gen Psychiatry 45:609-615
250. Weinberger DR (1987): Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44:660-669
251. Weinberger DR (1984): Computed tomography (CT) findings in schizophrenia: speculation on the meaning of it all. J Psychiatr Res 18(4):477-490
252. Weiss SR, Post RM, Pert A, Woodward R, Murman D (1989): Context-dependent cocaine sensitization: differential effect of haloperidol on development versus expression. Pharmacol Biochem Behavior 34(3):655-661
253. 3H]WIN 35,428 Binding in human caudate: pharmacological profile. Presented at the 23rd Annual Meeting of the Society for Neuroscience, Washington, DC
254. Wolf ME, White FJ, Nassar R, Brooderson RJ, Khansa MR (1993): Differential development of autoreceptor sub-sensitivity and enhanced dopamine release during amphetamine sensitization. J Pharmacol Exp Ther 264(1):249-255
255. Wolf ME, Khansa MR (1991): Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine. Brain Res 562(1):164-168
256. Wolkin A, Barouche F, Wolf AP, Rotrosen J, Fowler JS, Shiue CY, Cooper TB, Brodie JD (1989): Dopamine blockade and clinical response: evidence for two biological sub-groups of schizophrenia. Am J Psychiatry 146(7): 905-908
257. Wong DF, Wagner HN, Tune LE, Dannals RF, Pearlson GD, Links JM, Tamminga CA, Broussole EP, Ravert HT, Wilson AA, Toung JK, Malat J, Williams JA, O'Tuama LA, Snyder SH, Kuhar MJ, Gjedde A (1986): Positron emission tomography reveals elevated D2 dopamine receptors in drug naive schizophrenics. Science 234:1558-1563
258. Wyatt RJ (1991): Neuroleptics and the natural course of schizophrenia. Schizophr Bull 17(2):325-351
259. Wyatt RJ (1995): Early intervention for schizophrenia: Can the course of the illness be altered. Biol Psychiatry 38:1-3
260. Yoshikawa T, Shibuya H, Kaneno S, Toru M (1991): Blockade of behavioral sensitization to methamphetamine by lesion of hippocampal-accumbal pathway. Life Sci 48:1325-1332
261. Zigmond MJ, Abercrombie ED, Berger TW, Grace AA, Stricker EM (1990): Compensations after lesions of central dopaminergic neurons: some clinical and basic implications. Trends Neurosci 13(7):290-296
262. Zubin J, Spring B (1977): Vulnerability - a new view of schizophrenia. J Abn Psychology 86(2):103-126